Safety and effectiveness of immunotherapy in patients with indolent systemic mastocytosis presenting with Hymenoptera venom anaphylaxis
- 1 February 2008
- journal article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 121 (2) , 519-526
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Demonstration of an aberrant mast-cell population with clonal markers in a subset of patients with “idiopathic” anaphylaxisBlood, 2007
- EuropeanPolistesvenom allergyAllergy, 2006
- Insect sting allergy and venom immunotherapy: A model and a mysteryJournal of Allergy and Clinical Immunology, 2005
- Side‐effects of insect venom immunotherapy:results from an EAACI multicenter studyAllergy, 2000
- Double Sensitization to Honeybee and Wasp Venom: Immunotherapy with One or with Both Venoms?International Archives of Allergy and Immunology, 2000
- Bee sting allergy in beekeepersClinical & Experimental Allergy, 1998
- Sting anaphylaxis and urticaria pigmentosaJournal of Allergy and Clinical Immunology, 1998
- Rush Hymenoptera venom immunotherapy: Successful treatment in a patient with systemic mast cell diseaseJournal of Allergy and Clinical Immunology, 1994
- Guidelines for venom immunotherapyJournal of Allergy and Clinical Immunology, 1986
- Anaphylaxis after hymenoptera stings in three patients with urticaria pigmentosaJournal of Allergy and Clinical Immunology, 1983